• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • Webinars
  • Webinar: China NMPA Registration of Medical Devices, IVDs, and Medical Software

Webinar: China NMPA Registration of Medical Devices, IVDs, and Medical Software

Monday, 23 August 2021 / Published in Webinars

Webinar: China NMPA Registration of Medical Devices, IVDs, and Medical Software

On September 16, 2021, Cisema will be participating in Business Finland’s 2021 China Health Tech Series III to cover the following topics in the coaching session:

  • NMPA registration of medical devices, and IVDs
  • Software and its regulatory implications in China (SaMDs and SiMDs)
  • Regulatory hurdles
  • Regulatory updates & post-market surveillance
  • Alternative pathways

Background

The Chinese medical device industry is large and has good potential. In 2019, the industry was worth RMB 629 billion doubling its size in 2015. In 2020, due to strong demand for Covid-19 related medical devices, the industry’s value went up to RMB 800 billion. Overall, China’s medical device industry has been growing at a rate of 20% since 2015 and it now accounts for about 20% of the global medical device market share. Therefore it is a crucial market for Finnish health tech companies to consider.  

Agenda

10:00 – 10:05: Opening remarks by Business Finland

10:05 – 11:05: Coaching Session – “NMPA Registration of Medical Devices, IVDs, and software in China” by Cisema)

11:05 – 11:30: Q&A

Who should attend?

Finnish health tech companies with interests in China.

Registration link: TBA

Contact Cisema if you would like to learn more.

What you can read next

China Regulatory 2021 Deep-dive: Major Updates, IVD Regulatory Landscape, evolving Digital Health Frameworks
Webinar: China’s Digital Healthcare Opportunities and Regulatory Implications
Webinar: MedTech pathway to China: Market opportunities and regulatory hurdles
Webinar: MedTech pathway to China: Market opportunities and regulatory hurdles

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP